Literature DB >> 9694350

Virtual DNA analysis--a new tool for combination and standardised evaluation of SSO, SSP and sequencing-based typing results.

W Helmberg1, G Lanzer, R Zahn, B Weinmayr, T Wagner, E Albert.   

Abstract

In order to obtain reliable information on HLA types, DNA typing with sequence-specific oligonucleotide/primer (SSO/SSP) typing sets or sequencing-based typing (SBT) is increasingly performed. The quality of the evaluation depends on the presence of a complete listing of all typed alleles as well as on the ability of detecting all corresponding alleles/allele pairs. We have developed the concept of virtual DNA analysis (VDA), which is able to combine all types of SSO/SSP/SBT results and evaluate this typing in combination according to the latest published allele sequence lists. The concept is based on the target DNA recognised by the respective typing techniques. All SSO/SSP or SBT results are transformed to a virtual sample DNA, which subsequently is analysed. Evaluation of generic or allele-specific DNA typing or the combination of both is supported. Due to this flexible approach, all kinds of SSO/SSP sets, as far as the respective SSO/SSP sequences are available, can be entered and evaluated immediately. The combination of collected data of different typing sets and procedures leads to the highest possible typing resolution. If more than one possible allele combination persists, the program reduces the result to the most specific common denominator in a stepwise manner. VDA offers the possibility of re-evaluation of former SSO/SSP/SBT results, alone or in combination. No solutions are omitted. This might be a first step towards standardisation of evaluating DNA-based HLA typing results or transfer of the respective typing data for later evaluation.

Mesh:

Substances:

Year:  1998        PMID: 9694350     DOI: 10.1111/j.1399-0039.1998.tb03000.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  13 in total

1.  Standard methods for the management of immunogenetic data.

Authors:  Pierre-Antoine Gourraud; Jill A Hollenbach; Thomas Barnetche; Richard M Single; Steven J Mack
Journal:  Methods Mol Biol       Date:  2012

2.  Association of 22 cytokine gene polymorphisms with rheumatoid arthritis in population of ethnic Macedonians.

Authors:  Dejan Trajkov; Snezhana Mishevska-Perchinkova; Anzelika Karadzova-Stojanoska; Aleksandar Petlichkovski; Ana Strezova; Mirko Spiroski
Journal:  Clin Rheumatol       Date:  2009-08-07       Impact factor: 2.980

3.  Clinical features, biochemistry and HLA-DRB1 status in youth-onset type 1 diabetes in Pakistan.

Authors:  Asher Fawwad; Denira Govender; Mohammad Yakoob Ahmedani; Abdul Basit; Julie Ann Lane; Steven John Mack; Mark Alvin Atkinson; Clive Henry Wasserfall; Graham David Ogle; Janelle Annette Noble
Journal:  Diabetes Res Clin Pract       Date:  2019-01-30       Impact factor: 5.602

4.  Prevalence of celiac disease in Germany: a prospective follow-up study.

Authors:  Wolfgang Kratzer; Monika Kibele; Atilla Akinli; Marc Porzner; Bernhard O Boehm; Wolfgang Koenig; Suemeyra Oeztuerk; Richard A Mason; Ren Mao; Mark H Haenle
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

5.  HLA class I and II alleles are associated with microvascular complications of type 1 diabetes.

Authors:  E M Lipner; Y Tomer; J A Noble; M C Monti; J T Lonsdale; B Corso; W C L Stewart; D A Greenberg
Journal:  Hum Immunol       Date:  2013-01-29       Impact factor: 2.850

6.  Identification of a new HLA-B allele (B*1576) by haplotype specific extraction.

Authors:  Johannes Dapprich; Klaus Witter; Harrison W Gabel; Nancy B Murphy; Ekkehard D Albert
Journal:  Hum Immunol       Date:  2007-02-15       Impact factor: 2.850

7.  Concordance of next generation sequence-based and sequence specific oligonucleotide probe-based HLA-DRB1 genotyping.

Authors:  Julie A Lane; Jameel R Johnson; Janelle A Noble
Journal:  Hum Immunol       Date:  2015-08-04       Impact factor: 2.850

8.  HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium.

Authors:  Janelle A Noble; Ana Maria Valdes; Michael D Varney; Joyce A Carlson; Priscilla Moonsamy; Anna Lisa Fear; Julie A Lane; Eva Lavant; Rebecca Rappner; Anthony Louey; Patrick Concannon; Josyf C Mychaleckyj; Henry A Erlich
Journal:  Diabetes       Date:  2010-08-26       Impact factor: 9.461

9.  HLA associations in classical Hodgkin lymphoma: EBV status matters.

Authors:  Xin Huang; Kushi Kushekhar; Ilja Nolte; Wierd Kooistra; Lydia Visser; Ilby Bouwman; Niels Kouprie; Rianne Veenstra; Gustaaf van Imhoff; Bianca Olver; Richard S Houlston; Sibrand Poppema; Arjan Diepstra; Bouke Hepkema; Anke van den Berg
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

10.  Variation in the ATP-binding cassette transporter 2 gene is a separate risk factor for systemic lupus erythematosus within the MHC.

Authors:  P S Ramos; C D Langefeld; L A Bera; P M Gaffney; J A Noble; K L Moser
Journal:  Genes Immun       Date:  2009-04-23       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.